Nutrition Series Video 9: GLP-1s

In this video, Dr. Grant H. Garcia breaks down the critical relationship between GLP-1 receptor agonist medications (popular weight-loss and diabetes drugs) and surgical recovery, outlining the hidden nutritional risks they introduce for orthopedic patients.

Here is a summary of the core medical insights he shares:

• The Surgical Context of GLP-1s: While GLP-1 agonists are incredibly effective for weight management and reducing certain systemic inflammatory markers, they present modern pre-operative challenges that surgeons must now carefully manage.
• The Risk of Rapid Muscle Loss: Because these medications work primarily via appetite suppression, patients on them frequently experience a steep decline in their daily food intake. Dr. Garcia warns that this often drops a patient's protein intake far below the necessary "anabolic threshold" required for muscle maintenance. When a patient enters surgery already under-fueled, they face an accelerated risk of post-operative muscle wasting.
• The Danger of Delayed Gastric Emptying: Aside from nutritional concerns, GLP-1s physically slow down how quickly food leaves the stomach (delayed gastric emptying). This poses a serious risk under anesthesia, meaning patients must strictly follow medical guidelines to stop taking these medications for a specific period before their scheduled surgery.
• Targeted Pre-Operative Strategies: Dr. Garcia emphasizes that being on a GLP-1 is absolutely not a contraindication for surgery, but it does require proactive nutritional compensation. He recommends several targeted protocols:
  • High-Density Supplementation: Utilizing concentrated liquid protein supplements and essential amino acid formulas to easily bypass appetite suppression and hit daily protein targets.
  • Resistance Training Prehab: Participating in a structured pre-operative physical therapy and resistance training program to build and protect as much lean muscle mass as possible before the operation.